ENGINEERING SYNTHETIC GENE CIRCUITS FOR PRECISION REGULATION OF THERAPEUTIC PROTEIN EXPRESSION

Abstract

Background: Advanced synthetic gene circuits are sophisticated programmable systems that have emerged as a means to control the expression of therapeutic proteins with improved precision and cellular responsiveness. Traditional therapeutic expression systems usually suffer from uncontrolled gene activation, low targeting specificity, and increased off-target effects.

 Objective: The study evaluated engineered synthetic gene circuits for precise regulation of therapeutic protein expression using inducible promoters, CRISPR/dCas9-mediated transcriptional regulation, and computational optimization of the circuits.

Methodology. We analyzed 180 engineered mammalian cell cultures with synthetic regulatory networks, programmable promoters, and CRISPR-based gene regulation systems. The expression of therapeutic proteins was characterized by ELISA, fluorescence imaging, RNA-seq profiling, and computational regulatory modeling.

 Findings: We achieved 92% expression accuracy, 88% target-specific activation efficiency, and 90% dynamic responsiveness of synthetic gene circuits under inducible conditions. CRISPR-mediated regulation greatly reduced the off-target transcriptional activity and enhanced the stability of the therapeutic protein and the efficiency of regulation.

Conclusion: Engineered synthetic gene circuits can significantly enhance programmable control of therapeutic protein expression and have great potential in precision medicine, cancer therapeutics, regenerative medicine, and personalized gene therapy.